A start-up company led by top international researchers in gut microbiology and immunity
Ibiome Biology Co., Ltd, Ltd. is a biotechnology company focusing on the innovative research and development of human gut microbiota, and a start-up company led by top international researchers in gut microbiology and immunity. The core R&D team consists of scientists from top international universities such as Yale University, Harvard Medical School, and University of Science and Technology of China.
The company's core business is the development of intestinal bacteria drugs, and the immunotherapy of human intestinal microorganisms. Develop clinical treatment solutions including metabolic diseases, anti-tumor, inflammatory bowel disease, autoimmune diseases, etc., marking the development of the largest domestic and international immunomodulatory strains development enterprise.
The company's core R&D team is composed of many scientists from top international universities such as Yale University, Harvard Medical School, University of Science and Technology of China, Chinese Academy of Sciences, etc., and has a solid working foundation in the research of intestinal microbes, host immunity, and intestinal microbe-related diseases. , research results have been published in top international journals for many times.
Cell (2021), Nature Reviews Gastroenterology & Hepatology, (2021), PNAS (2021), Nature Immunology (2019), Nature (2017a, 2017b), Science (2015), Nat Comm (2015).
Yale University
Harvard University
University of Science and Technology of China
Chinese Academy of Sciences
Richard Flavell, PhD
—
Professor, Yale University
Immunology
IBD
Immune-Microbiome
WengJianping, Ph.D.
—
Chinese Academy of Sciences Clinical
Hospital Dean
Endocrine metabolism
disease
Eran Elinav, MD,PhD
—
Professor, Weizmannx Institute
Microbiome
Personized nutrition
Microbiota
ZhaoShen Li, Ph.D.
—
Chinese Academy of Engineering
academician
Changhai Hospital Digestion
Director of Internal Medicine
Noah Palm, PhD
—
Assistant Professor,
Yale University
Microbial metabolites
IgA sequencing
Hong Zhang, Ph.D.
—
Peking University First Hospital Kidney
Deputy Director of Internal Medicine
IgA nephropathy
Red , (co)first or corresponding author ; Blue , coauthor
Address: 16th Floor, Building E, Intelligent Equipment Technology Park, No. 3963, Susong Road, Economic and Technological Development Zone, Hefei City
Tel: 0551-63813386
Email: hr@ibiome.com.cn